Xinyu Jiang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Xinyu Jiang has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Chen Ying
Department of Urology, Haicang Hospital of Xiamen, Xiamen, Fujian 361026, P.R. China
1 shared publicationDongbo Feng
Department of Sports Medicine, The Central Hospital of Yongzhou, Yongzhou, Hunan 425000, P.R. China
1 shared publicationFulv Liang
Department of Urology, The Third Hospital of Xiamen, Xiamen, Fujian 361000, P.R. China
1 shared publicationMaolin Zhang
Department of Surgery, Xiapu County Hospital, Xiapu County, Ningde, Fujian 355100, P.R. China
1 shared publicationWei Ye
Department of Neurology, Jianou Municipal Hospital, Jianou, Fujian 353100, P.R. China
1 shared publication
Latest Publications
- Open Access
- 13 September 2019
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 18 (5) , 3729-3736
Downregulation of microRNA‑3934‑5p induces apoptosis and inhibits the proliferation of neuroblastoma cells by targeting TP53INP1
Neuroblastoma is the most common pediatric extracranial solid tumour in the world. miRNAs are a group of endogenous small non‑coding RNAs that act on target genes to serve critical roles in many biological processes. Presently, the expression and role of miR‑3934‑5p in neuroblastoma remains unclear. Therefore, the aim of the present study was to investigate the expression of miR‑3934‑5p in neuroblastoma tissues and cell lines and to assess the role of miR‑3934‑5p in neuroblastoma. In the current study, the results revealed that miR‑3934‑5p was significantly upregulated in neuroblastoma tissues and cell lines. The data also identified TP53INP1 as a direct target gene of miR‑3934‑5p, which was negatively regulated by miR‑3934‑5p. The present study further demonstrated that TP53INP1 was downregulated in both neuroblastoma tissues and cell lines. Furthermore, the results of the current study indicate that miR‑3934‑5p downregulation may induce apoptosis and inhibit neuroblastoma cell viability. However, these effects were reversed via TP53INP1‑siRNA. Data from the current study indicates that the miR‑3934‑5p/TP53INP1 axis may be a novel therapeutic target for neuroblastoma treatment.
- 13 September 2019
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 18 (5) , 3729-3736
Open AccessDownregulation of microRNA‑3934‑5p induces apoptosis and inhibits the proliferation of neuroblastoma cells by targeting TP53INP1
Neuroblastoma is the most common pediatric extracranial solid tumour in the world. miRNAs are a group of endogenous small non‑coding RNAs that act on target genes to serve critical roles in many biological processes. Presently, the expression and role of miR‑3934‑5p in neuroblastoma remains unclear. Therefore, the aim of the present study was to investigate the expression of miR‑3934‑5p in neuroblastoma tissues and cell lines and to assess the role of miR‑3934‑5p in neuroblastoma. In the current study, the results revealed that miR‑3934‑5p was significantly upregulated in neuroblastoma tissues and cell lines. The data also identified TP53INP1 as a direct target gene of miR‑3934‑5p, which was negatively regulated by miR‑3934‑5p. The present study further demonstrated that TP53INP1 was downregulated in both neuroblastoma tissues and cell lines. Furthermore, the results of the current study indicate that miR‑3934‑5p downregulation may induce apoptosis and inhibit neuroblastoma cell viability. However, these effects were reversed via TP53INP1‑siRNA. Data from the current study indicates that the miR‑3934‑5p/TP53INP1 axis may be a novel therapeutic target for neuroblastoma treatment.